`

Cabaletta Bio

Biotechnology Research

Specialities :
Cell therapy
Biotech
Immunology
Autoimmune
And rheumatology
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
51 - 200

Frequently Asked Questions About Cabaletta Bio

What does Cabaletta bio do?+

Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies that have the potential to provide a deep and durable, perhaps curative, treatment for patients with autoimmune diseases. The CABATM platform encompasses two strategies: the CARTA (chimeric antigen receptor T cells for autoimmunity) strategy, with CABA-201, a 4-1BB-containing fully human CD19-CAR T, as the lead product candidate being evaluated in systemic lupus erythematosus and myositis, and the CAART (chimeric autoantibody receptor T cells) strategy, with multiple clinical-stage candidates, including DSG3-CAART for mucosal pemphigus vulgaris and MuSK-CAART for MuSK myasthenia gravis....

What are Cabaletta bio's specialties? +

Cell therapy,biotech,immunology,autoimmune,and rheumatology

What is Cabaletta bio's industry? +

Cabaletta bio operates in the Biotechnology research industry.

What is Cabaletta bio's revenue? +

Cabaletta bio's revenue is 11m - 100m

What is Cabaletta bio's company size? +

Cabaletta bio has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.